334 related articles for article (PubMed ID: 30626627)
1. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
4. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
[TBL] [Abstract][Full Text] [Related]
5. BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1.
Zhu S; Zhao D; Yan L; Jiang W; Kim JS; Gu B; Liu Q; Wang R; Xia B; Zhao JC; Song G; Mi W; Wang RF; Shi X; Lam HM; Dong X; Yu J; Chen K; Cao Q
Nat Commun; 2018 Feb; 9(1):500. PubMed ID: 29402932
[TBL] [Abstract][Full Text] [Related]
6. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
Udayakumar TS; Hachem P; Ahmed MM; Agrawal S; Pollack A
Mol Cancer Res; 2008 Nov; 6(11):1742-54. PubMed ID: 19010821
[TBL] [Abstract][Full Text] [Related]
7. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
[TBL] [Abstract][Full Text] [Related]
9. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
Sabnis NG; Miller A; Titus MA; Huss WJ
Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
[TBL] [Abstract][Full Text] [Related]
10. Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer.
Lakshmikanthan V; Zou L; Kim JI; Michal A; Nie Z; Messias NC; Benovic JL; Daaka Y
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9379-84. PubMed ID: 19458261
[TBL] [Abstract][Full Text] [Related]
11. Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells.
Logan IR; McClurg UL; Jones DL; O'Neill DJ; Shaheen FS; Lunec J; Gaughan L; Robson CN
Oncotarget; 2016 Nov; 7(46):74724-74733. PubMed ID: 27729622
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Deng Q; Tang DG
Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
[TBL] [Abstract][Full Text] [Related]
14. Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly.
Felten A; Brinckmann D; Landsberg G; Scheidtmann KH
Oncogene; 2013 Oct; 32(41):4981-8. PubMed ID: 23146908
[TBL] [Abstract][Full Text] [Related]
15. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract][Full Text] [Related]
16. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity.
McClurg UL; Cork DMW; Darby S; Ryan-Munden CA; Nakjang S; Mendes Côrtes L; Treumann A; Gaughan L; Robson CN
Nucleic Acids Res; 2017 Feb; 45(4):1793-1804. PubMed ID: 27903893
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
[TBL] [Abstract][Full Text] [Related]
19. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling.
Schroeder A; Herrmann A; Cherryholmes G; Kowolik C; Buettner R; Pal S; Yu H; Müller-Newen G; Jove R
Cancer Res; 2014 Feb; 74(4):1227-37. PubMed ID: 24177177
[TBL] [Abstract][Full Text] [Related]
20. The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis.
Kong L; Yuan Q; Zhu H; Li Y; Guo Q; Wang Q; Bi X; Gao X
Biomaterials; 2011 Sep; 32(27):6515-22. PubMed ID: 21640377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
